| 價(jià)格 | ¥192 | ¥492 | ¥793 |
| 包裝 | 1mg | 5mg | 10mg |
| 最小起訂量 | 1mg |
| 發(fā)貨地 | 上海 |
| 更新日期 | 2026-06-29 |
| 中文名稱:化合物 LM22A-4 | 英文名稱:LM22A-4 |
| CAS:37988-18-4 | 品牌: TargetMol |
| 產(chǎn)地: 美國 | 保存條件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| 純度規(guī)格: 99.56% | 產(chǎn)品類別: 抑制劑 |
| 貨號(hào): T001|T7568 |
| 名稱 | LM22A-4 |
| 描述 | LM22A-4 is a brain-derived neurotrophic factor (BDNF) mimetic and agonist of the receptor tropomyosin-related kinase B (TrkB; IC50 : 47 nM in a fluorescence anisotropy assay) |
| 動(dòng)物實(shí)驗(yàn) | Wt and Het littermates were divided into 4 groups: Wt vehicle-treated (100 μl of 0.9% NaCl, i.p., b.i.d.), Wt drug-treated (50 mg/kg LM22A-4 in 0.9% NaCl, i.p., b.i.d.), Het vehicle-treated (100 μl of 0.9% NaCl, i.p., b.i.d.), and Het drug-treated (50 mg/kg LM22A-4 in 0.9% NaCl, i.p., b.i.d.).?Each mouse was treated from 8 to 13 weeks of age.?Whole-body plethysmography was performed during week 12 and animals were subsequently killed and tissues harvested for TrkB Western blots and BDNF ELISA during week[1]. |
| 體外活性 | 在體外實(shí)驗(yàn)中,LM22A-4通過激活TrkB以及下游的Akt和ERK促生存信號(hào)通路,增加了海馬神經(jīng)元的存活率[1]。 |
| 體內(nèi)活性 | 將Het小鼠用LM22A-4處理4周,能夠在延髓和橋腦中恢復(fù)TrkB磷酸化的野生型水平,并且恢復(fù)了野生型的呼吸頻率[1]。 |
| 存儲(chǔ)條件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| 溶解度 | H2O : 50 mg/mL (147.34 mM), Sonication is recommended. DMSO : 125 mg/mL (368.36 mM), Sonication is recommended. 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 2 mg/mL (5.89 mM), Sonication is recommended. 10% DMSO+90% Saline : 10 mg/mL (29.47 mM), Solution. |
| 關(guān)鍵字 | Tropomyosin related kinase receptor | Trkreceptor | Trk Receptor | Trk | LM22A-4 | LM-22A-4 | LM22A4 | LM22A 4 | Inhibitor | inhibit |
| 相關(guān)產(chǎn)品 | Larotrectinib | Tepotinib | Taletrectinib | Amitriptyline hydrochloride | NSI-189 Phosphate | N-Acetyl-5-hydroxytryptamine | GW 441756 | SP600125 | Larotrectinib sulfate | Amitriptyline | ALE-0540 | 7,8-Dihydroxyflavone |
| 相關(guān)庫 | 經(jīng)典已知活性庫 | 已知活性化合物庫 | 激酶抑制劑庫 | NO PAINS 化合物庫 | 膜蛋白靶向化合物庫 | 酪氨酸激酶分子庫 | 蛋白翻譯后修飾化合物庫 |
| 成立日期 | 2013-04-18 (14年) | 注冊(cè)資本 | 566.265100萬人民幣 |
| 員工人數(shù) | 100-500人 | 年?duì)I業(yè)額 | ¥ 1億以上 |
| 主營行業(yè) | 天然產(chǎn)物,生化試劑,分子生物學(xué),分子砌塊,生物技術(shù)服務(wù) | 經(jīng)營模式 | 貿(mào)易,工廠,試劑,定制,服務(wù) |
| 產(chǎn)品名稱 | 價(jià)格 | 公司名稱 | 報(bào)價(jià)日期 | |
|---|---|---|---|---|
| 詢價(jià) |
VIP4年
|
陜西西化化學(xué)工業(yè)有限公司
|
2026-05-25 | |
| ¥6000 |
上海聚米合創(chuàng)生物醫(yī)藥科技有限公司
|
2026-06-29 | ||
| 詢價(jià) |
VIP3年
|
上海杰瑞興生物醫(yī)藥科技有限公司
|
2026-08-04 | |
| 詢價(jià) |
VIP1年
|
陜西締都醫(yī)藥有限責(zé)任公司
|
2026-08-03 | |
| ¥1065.90 |
VIP3年
|
上海阿拉丁生化科技股份有限公司
|
2026-06-10 |